T cells were engineered with such allorestricted TCR specific for chondromodulin-I/HLA-A*02:01 to target metastatic Ewing sarcoma cells as reported by Stefan Burdach (Department of Pediatrics and Children's Cancer Research Center, Kinderklinik München Schwabing, Technische Universität München, Munich, Germany). This evidence concerns the gene CNMD and Ewing sarcoma.